KAMADA LTD (KMDA)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (3)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06958796 | Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) | PHASE4 | Recruiting | 80 |
| NCT07009548 | CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients | PHASE4 | Enrolling By Invitation | 45 |
| NCT04204252 | Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation" | PHASE3 | Recruiting | 220 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.